References

1. Malik RA. Current and future strategies for the management of diabetic neuropathy. Treat Endocrinol 2003;2:389-400.

2. Young MJ, Boulton AJ, McLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the UK hospital clinic population. Diabetologia 1993;36:150-156.

3. Cabezas-Cerrato J. The prevalence of diabetic neuropathy in Spain: a study in primary care and hospital clinic groups. Diabetologia 1998;41:1263-1269.

4. Scott J, Huskisson EC. Graphic representation of pain. Pain 1976;2:175-186.

5. Meijer JW, Smit AJ, Sondersen EV, Groothoff JW, Eisma WH, Links TP. Symptom scoring systems to diagnose distal polyneuropathy in diabetes; the Diabetic Neuropathy Symptom Score. Diabetic Med 2002;19:962-965.

6. Zelman DC, Gore M, Dukes E, Tai KS, Brandenburg N. Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy. J Pain Symptom Manage 2005;29:401-410.

7. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324-1334.

8. Frampton JE, Scott LJ. Pregabalin: in the treatment of painful diabetic peripheral neuropathy. Drugs 2004;64:2813-2820.

9. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004; 110:697-706.

10. Vileikyte L, Peyrot M, Bundy C, et al. The development and validation of a neuropathy-and foot ulcer-specific quality of life instrument. Diabetes Care 2003;26:2549-2555.

11. Atli A, Dogra S. Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study. Pain Med 2005;6:225-234.

12. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005;116:109-118.

13. Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005;6:253-260.

14. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004;21:114-121.

15. Dyck PJ, Karnes J, O'Brien PC, Swanson CJ. Neuropathy symptom profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology 1986;36:1300-1308.

16. Dyck PJ, Kratz KM, Lehman KA, et al. The Rochester diabetic neuropathy study: Design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991;41:799-807.

17. Young RJ, Zhou YQ, Rodriguez E, Prescott RJ, Ewing DJ, Clarke BF. Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes 1986;35:192-197.

18. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004;27:1458-1486.

19. Abbott CA, Carrington AL, Ashe H, et al. North-West Diabetes Foot Care Study. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002;19:377-384.

20. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-1289.

21. Bril V, Perkins bA. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 2002;25:2048-2052.

22. Dyck PJ, Dyck PJ, Velosa JA, Larson TS, O'Brien PC. The Nerve Growth Factors Study Group. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy. A study of three cohorts. Diabetes Care 2000;23:510.

23. Sosenko JM, Kato M, Soto R, Bild DE. Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients. Diabetes Care 1990;13:1057-1061.

Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DC, Giuliani MJ. Quantitative sensory testing: report of the Therapeutics and Technology Assessment the Subcommittee of the American Academy of Neurology. Neurology 2003;602:898-906. Apfel SC, Schwartz S, Adornato BT, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. JAMA 2000;284:2215-2221.

Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindstrom P, Wahren J. Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes. Diabetes 2003;52:536-541.

Dillingham TR, Pezzin LE. Under-recognition of polyneuropathy in persons with diabetes by non-physician electrodiagnostic services providers. Am J Phys Med Rehabil 2005;84:399-406.

Hohman TC, Cotter MA, Cameron NE. ATP-sensitive K (+) channel effects on nerve function, Na (+), K (+) ATPase, and glutathione in diabetic rats. Eur J Pharmacol 2000;3(397):335-341.

Peripheral Nerve Society: Diabetic polyneuropathy in controlled clinical trials: consensus report of the peripheral nerve society. Am Neurol 1995;38:478-482. Valk GD, Grootenhuis PA, van Eijk JT, Bouter LM, Bertelsmann FW. Methods for assessing diabetic polyneuropathy: validity and reproducibility of the measurement of sensory symptom severity and nerve function tests. Diabetes Res Clin Pract 2000;47:87-95. Herrmann DN, Ferguson ML, Logigian EL. Conduction slowing in diabetic distal polyneuropathy. Muscle Nerve 2002;26:232-237.

Malik RA, Tesfaye S, Newrick PG, et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005;48:578-585. DCCT research group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Int Med 1995;122:561-568.

Amthor KF, Dahl-Jorgensen K, Berg TJ, et al. The effect of 8 years of strict glycaemia control on peripheral nerve function in IDDM patients: the Oslo Study. Diabetologia 1994; 37:579-784.

Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes. NEJM 1995;333: 39-84.

Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Klein CJ, Dyck PJ. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy. Diabetes Care 2005;28:2192-2200.

Misawa S, Kuwabara S, Kanai K, et al. Axonal potassium conductance and glycemic control in human diabetic nerves. Clin Neurophysiol 2005;116:1181-1187. Veves A, Malik RA, Lye RH, et al. The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. Diabetic Med 1991;8:917-921.

Russell JW, Karnes JL, Dyck PJ. Sural nerve myelinated fibre density differences associated with meaningful changes in clinical and electrophysiologic measurements. J Neurol Sci 1996;135:114-117.

Kohara N, Kimura J, Kaji R, et al. F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy. Diabetologia 2000;43:915-921. Caccia MR, Salvaggi A, Dezuanni E. An electrophysiological method to assess the distribution of the sensory propagation velocity of the digital nerve in normal and diabetic subjects. Electroencephal Clin Neurophysiol 1993;89:88-94.

Bertora P, Valla P, Dezuanni E. Prevalence of subclinical neuropathy in diabetic patients: assessment by study of conduction velocity distribution within motor and sensory nerve fibres. J Neurol 1998;245:81-86.

43. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 1997;49:229-239.

44. Apfel SC, Schwartz S, Adornato BT, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. JAMA 2000;284:2215-2221.

45. Magerl W, Treede RD. Heat-evoked vasodilatation in human hairy skin: axon reflexes due to low-level activity of nociceptive afferents. J Physiol 1996;15:837-848.

46. Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care 2001;24:344-349.

47. Krishnan ST, Rayman G. The LDIflare: a novel test of C-fibre function demonstrates early neuropathy in type 2 diabetes. Diabetes Care 2004;27:2930-2935.

48. Thomas PK. Nerve biopsy. Diabetic Med 1997;16:351-352.

49. Dahlin LB, Erikson KF, Sundkvist G. Persistent postoperative complaints after whole nerve sural nerve biopsies in diabetic and non-diabetic subjects. Diabetic Med 1997;14:353-356.

50. Greene DA, Arezzo JC, Brown MB. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group. Neurology 1999;53:580-591.

51. Sima AA, Calvani M, Mehra M, Amato A. Acetyl-L-Carnitine Study Group. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care 2005;28:89-94.

52. McCarthy BG, Hsieh ST, Stocks A, et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995;45:1848-1855.

53. Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 1998;44:47-59.

54. Polydefkis M, Griffin W, McArthur J. New insights into diabetic polyneuropathy. JAMA 2003;371-1376.

55. Koskinen M, Hietaharju A, Kylaniemi M, et al. A quantitative method for the assessment of intraepidermal nerve fibres in small-fibre neuropathy. J Neurol 2005;252:789-794.

56. Yaneda H, Tereda M, Maeda K, et al. Diabetic neuropathy and nerve regeneration. Prog Neurobiol 2003;69:229-285.

57. Eaton SE, Harris ND, Rajbhandari SM, et al. Spinal-cord involvement in diabetic peripheral neuropathy. Lancet 2001;358:35-36.

58. Oliviera-soto L, Efron N. Morphology of corneal nerves using confocal microscopy. Cornea 2001;21:246-248.

59. Malik RA, Kallinikos P, Abbott CA, et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 2003;46: 683-688.

60. Kallinikos P, Berhanu M, O'Donnell C, et al. Corneal nerve tortuosity in diabetic patients with neuropathy. Invest Ophthalmol Vis Sci 2004;45:418-422.

61. Iqbal I, Kallinikos P, Boulton AJ, Efron N, Malik RA. Corneal nerve morphology: A surrogate marker for human diabetic neuropathy improves with improved glycaemic control. Diabetes 2005;54:871.

62. Kastenbauer T, Sauseng S, Brath H, Abrahamian H, Irsigler K. The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothe-siometer. Diabet Med 2004;21:563-567.

63. Young MJ, Breddy JL, Veves A, Boulton AJM. The prediction of diabetic foot ulceration using vibration thresholds: A prospective study. Diabetes Care 1994;17:557-560.

64. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 2000;23:606-611.

65. Nicolucci A, Carnici F, Cavaliere D, et al. On behalf of the Italian study group for the implementation of the St. Vincent Declaration. A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. Diabet Med 1996;13: 1017-1026.

66. Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindstrom P, Wahren J. Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes. Diabetes 2003;52: 536-541.

Peripheral Neuropathy Natural Treatment Options

Peripheral Neuropathy Natural Treatment Options

This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.

Get My Free Ebook


Post a comment